688029 南微医学
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)12.89614.87614.21510.71911.694
总资产报酬率 ROA (%)10.21412.06311.7288.7869.641
投入资产回报率 ROIC (%)12.12214.27113.70410.46711.551

边际利润分析
销售毛利率 (%)64.55067.65364.50460.95064.181
营业利润率 (%)26.31023.93123.00118.39118.862
息税前利润/营业总收入 (%)23.28822.14020.19815.51420.454
净利润/营业总收入 (%)22.26820.61720.51416.80916.918

收益指标分析
经营活动净收益/利润总额(%)99.684104.75198.62793.49386.167
价值变动净收益/利润总额(%)1.6723.0364.92811.75217.328
营业外收支净额/利润总额(%)0.0510.0551.8131.0092.692

偿债能力分析
流动比率 (X)4.0244.1185.0675.3434.665
速动比率 (X)3.2993.4524.2644.3274.010
资产负债率 (%)18.27018.41716.44815.91017.662
带息债务/全部投入资本 (%)5.9002.1412.1991.1310.318
股东权益/带息债务 (%)1,562.2944,483.7954,358.7378,580.46630,894.838
股东权益/负债合计 (%)429.242434.663499.910520.536458.858
利息保障倍数 (X)-7.675-12.267-6.258-5.06419.103

营运能力分析
应收账款周转天数 (天)55.32255.13751.67057.92151.787
存货周转天数 (天)185.984213.687228.962223.846157.347